The Wuhan National Bio-industry Base, also known as the Biolake, is China's second largest State-level biotech industrial base in terms of its overall technological and commercial strength. It is located in the Wuhan East Lake High-tech Development Zone. [Photo/WeChat account of Optics Valley of China]

The East Lake High-tech Development Zone – which is also known as Optics Valley of China, or the OVC and based in Wuhan, capital city of Central China's Hubei province – was recently made one of 20 national key high-tech zones and development zones at the 14th China Bioindustry Convention.

The convention was held in Guangzhou city, capital of South China's Guangdong province, on June 10-12. At it, the "China Biomedical Industry Development Index" was released, as were the evaluation results of the regional biomedical industry in 2021.

The index is said to provide a comprehensive, dynamic and all-round evaluation of China's biomedical industry in terms of its resource inputs, performance outputs, corporate innovation and international influence. The index increased 26.5 percent year-on-year to 173.5 in 2021. 

Optics Valley of China boasts expanding health and biotechnology clusters and its strength in biomedicines ranks among the top high-tech zones in China.

It has formed a full-chain innovation support system covering scientific and technological innovation, achievement incubation, pilot production, inspection and testing and clinical applications.

There are dozens of innovative pharmaceutical companies there, as well as 33 national and provincial biomedicine innovation platforms.